Based on these findings, we hypothesised that ORes exert their effects by inhibiting EGFR, thereby modulating the PI3K-AKT pathway, suppressing GPX4 activity, and inducing ferroptosis in breast cancer cells. The gene discussed is PIK3CA; the disease is breast cancer.